UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055467
Receipt number R000063374
Scientific Title Analysis of diagnostic criteria for chronic endometritis and endometrial dysbiosis affecting pregnancy outcomes in assisted reproductive technology
Date of disclosure of the study information 2024/10/15
Last modified on 2025/03/11 09:29:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of diagnostic criteria for chronic endometritis and endometrial dysbiosis affecting pregnancy outcomes in assisted reproductive technology

Acronym

Analysis of diagnostic criteria for chronic endometritis and abnormality of endometrial microbiota affecting pregnancy outcomes in IVF treatment

Scientific Title

Analysis of diagnostic criteria for chronic endometritis and endometrial dysbiosis affecting pregnancy outcomes in assisted reproductive technology

Scientific Title:Acronym

Diagnostic criteria for chronic endometritis and endometrial dysbiosis affecting pregnancy outcomes

Region

Japan


Condition

Condition

Infertility

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the diagnostic criteria for chronic endometritis and endometrial dysbiosis through comparison between the number of endometrial CD138 positive cells or the results of microbiome analysis and pregnancy outcomes after blastocyst transfer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The number of endometrial CD138 positive cells or the results of microbiome analysis for therapeutic targets

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Female

Key inclusion criteria

Infertile women who have undergone assisted reproductive technology and meet the following conditions
(1) Under 40 years old
(2) History of one or more implantation failure after embryo transfer (including biochemical pregnancy)
(3) No intrauterine disorders after hysteroscopy or hysteroscopic surgery within 1 year
(4) hCG <5.0 mIU/mL at the day of pregnancy test
(5) No history of treatment for chronic endometritis
(6) No use of probiotics or lactoferrin supplements
(7) Women who have frozen morphologically good blastocysts (blastocysts without grade C of Gardner's classification) and will perform embryo transfer with their blastocysts in the next cycle

Key exclusion criteria

Women without the above diagnostic criteria

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Keiji
Middle name
Last name Kuroda

Organization

Sugiyama Clinic Marunouchi

Division name

Center for Reproductive Medicine and Endoscopy

Zip code

100-0005

Address

1-6-2, Marunouchi, Chiyoda-ku, Tokyo

TEL

+81-(0)3-5222-1500

Email

kuroda@sugiyama.or.jp


Public contact

Name of contact person

1st name Sayaka
Middle name
Last name Kitagawa

Organization

Sugiyama Clinic Marunouchi

Division name

Center for Reproductive Medicine and Endoscopy

Zip code

100-0005

Address

1-6-2, Marunouchi, Chiyoda-ku, Tokyo

TEL

+81-(0)3-5222-1500

Homepage URL


Email

kuroda@sugiyama.or.jp


Sponsor or person

Institute

Sugiyama Clinic Marunouchi

Institute

Department

Personal name



Funding Source

Organization

Japan society for the promotion of science

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sugiyama Clinic

Address

Nishi-shinjuku, 1-19-6, Shinjuku-ku, Tokyo

Tel

+81-(0)3-5381-3000

Email

kuroda@sugiyama.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 09 Month 08 Day

Date of IRB

2024 Year 10 Month 18 Day

Anticipated trial start date

2024 Year 11 Month 01 Day

Last follow-up date

2028 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study


Management information

Registered date

2024 Year 09 Month 09 Day

Last modified on

2025 Year 03 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063374